Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P26367: Variant p.Arg19Pro

Paired box protein Pax-6
Gene: PAX6
Feedback?
Variant information Variant position: help 19 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Arginine (R) to Proline (P) at position 19 (R19P, p.Arg19Pro). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and basic (R) to medium size and hydrophobic (P) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In AN1. Any additional useful information about the variant.


Sequence information Variant position: help 19 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 422 The length of the canonical sequence.
Location on the sequence: help MQNSHSGVNQLGGVFVNG R PLPDSTRQKIVELAHSGARP The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         MQNSHSGVNQLGGVFVNGRPLPDSTRQKIVELAHSGARP

Mouse                         MQNSHSGVNQLGGVFVNGRPLPDSTRQKIVELAHSGARP

Rat                           MQNSHSGVNQLGGVFVNGRPLPDSTRQKIVELAHSGARP

Bovine                        MQNSHSGVNQLGGVFVNGRPLPDSTRQKIVELAHSGARP

Xenopus laevis                MQNSHSGVNQLGGVFVNGRPLPDSTRQKIVELAHSGARP

Zebrafish                     MQNSHSGVNQLGGVFVNGRPLPDSTRQKIVELAHSGARP

Drosophila                    DDECHSGVNQLGGVFVGGRPLPDSTRQKIVELAHSGARP
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 422 Paired box protein Pax-6
DNA binding 4 – 130 Paired
Region 7 – 63 PAI subdomain



Literature citations
Screening for PAX6 gene mutations is consistent with haploinsufficiency as the main mechanism leading to various ocular defects.
Vincent M.-C.; Pujo A.-L.; Olivier D.; Calvas P.;
Eur. J. Hum. Genet. 11:163-169(2003)
Cited for: VARIANTS AN1 PRO-19 AND 22-PRO--ARG-26 DEL; Molecular findings and clinical data in a cohort of 150 patients with anophthalmia/microphthalmia.
Chassaing N.; Causse A.; Vigouroux A.; Delahaye A.; Alessandri J.L.; Boespflug-Tanguy O.; Boute-Benejean O.; Dollfus H.; Duban-Bedu B.; Gilbert-Dussardier B.; Giuliano F.; Gonzales M.; Holder-Espinasse M.; Isidor B.; Jacquemont M.L.; Lacombe D.; Martin-Coignard D.; Mathieu-Dramard M.; Odent S.; Picone O.; Pinson L.; Quelin C.; Sigaudy S.; Toutain A.; Thauvin-Robinet C.; Kaplan J.; Calvas P.;
Clin. Genet. 86:326-334(2014)
Cited for: VARIANT AN1 PRO-19;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.